Vitae

City of Regina Seeks Artist to Showcase Art in Public Park

Retrieved on: 
Friday, February 9, 2024
Vitae, Partnership, City, Letter, CST, Curriculum vitae, Tourism

REGINA, Saskatchewan, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The City of Regina has opened a Call for Artists to submit proposals for the creation of a new, original public artwork to install in Horizon Station Park.

Key Points: 
  • REGINA, Saskatchewan, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The City of Regina has opened a Call for Artists to submit proposals for the creation of a new, original public artwork to install in Horizon Station Park.
  • This is a land developer-funded civic art project in partnership with The Towns Development.
  • The intention is to increase the cultural value of Horizon Station Park by creating a public art installation that reflects the underrepresented stories of Saskatchewan’s railways and acknowledges difficult truths related to its legacy.
  • The deadline for proposal submission is March 4, 2024, at 4:00 p.m. CST, with installation of the art piece by October of 2024.

Serotonin Anti-Aging Centers to Debut in Texas with 6-Unit Development Deal

Retrieved on: 
Friday, January 26, 2024
Vitae, Hormone replacement therapy, Patient, PRP, MD, Health, Collagen induction therapy, Elective surgery, Athlete, HBOT, Map, HRT, DFW, Day, Growth

DALLAS, Jan. 26, 2024 /PRNewswire/ -- Optimus Vitae LLC announced today the upcoming opening of six new Serotonin Anti-Aging Centers in the Dallas-Fort Worth Metropolitan market. The nation's fastest growing anti-aging/longevity franchise plans to open the doors to its first two locations in Fort Worth and Mansfield within a year.

Key Points: 
  • DALLAS, Jan. 26, 2024 /PRNewswire/ -- Optimus Vitae LLC announced today the upcoming opening of six new Serotonin Anti-Aging Centers in the Dallas-Fort Worth Metropolitan market.
  • "The growth in Texas mirrors the growth of Serotonin and I'm excited to see the impact we will have on the health and performance of the great people of Texas."
  • With 97 franchises open and under development, Serotonin is positioned to lead the MedSpa and anti-aging industries just as demand in the sector escalates.
  • To learn more about Serotonin Anti-Aging Centers and its franchising opportunities, visit www.serotonincenters.com/franchising/ .

Univar Solutions Named on TIME's Best Companies for Future Leaders 2024 List

Retrieved on: 
Tuesday, December 19, 2023
Vitae, Statista, Culture, TIME, Government, Research, Univar Solutions, Education, Curriculum, Statistics, Future, Ambition Institute, Organization, Life, Management

DOWNERS GROVE, Ill., Dec. 19, 2023 /PRNewswire/ -- Univar Solutions Inc. ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that it has been named on TIME's Best Companies for Future Leaders 2024 list.

Key Points: 
  • DOWNERS GROVE, Ill., Dec. 19, 2023 /PRNewswire/ -- Univar Solutions Inc. ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that it has been named on TIME's Best Companies for Future Leaders 2024 list.
  • "We're pleased to have received a leadership score of 91 with a ranking of 61 on this inaugural list," said David Jukes, president, and chief executive officer.
  • "Growing our people and culture is core at Univar Solutions as we put the customer at the center of all we do."
  • The list of the "Best Companies for Future Leaders" was assembled based on the analysis of approximately 2,000 of the most influential leaders in the USA, coming from the worlds of business, government, academia, and society.

Univar Solutions Named on TIME's Best Companies for Future Leaders 2024 List

Retrieved on: 
Tuesday, December 19, 2023
Vitae, Statista, Culture, TIME, Government, Research, Univar Solutions, Education, Curriculum, Statistics, Future, Ambition Institute, Organization, Life, Management

DOWNERS GROVE, Ill., Dec. 19, 2023 /PRNewswire/ -- Univar Solutions Inc. ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that it has been named on TIME's Best Companies for Future Leaders 2024 list.

Key Points: 
  • DOWNERS GROVE, Ill., Dec. 19, 2023 /PRNewswire/ -- Univar Solutions Inc. ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that it has been named on TIME's Best Companies for Future Leaders 2024 list.
  • "We're pleased to have received a leadership score of 91 with a ranking of 61 on this inaugural list," said David Jukes, president, and chief executive officer.
  • "Growing our people and culture is core at Univar Solutions as we put the customer at the center of all we do."
  • The list of the "Best Companies for Future Leaders" was assembled based on the analysis of approximately 2,000 of the most influential leaders in the USA, coming from the worlds of business, government, academia, and society.

HireRight Launches Brazil Entity, Strengthening Market Position in Latin America

Retrieved on: 
Monday, November 6, 2023
Consulting, Labor, Professional Services, Public Policy, Government, Human Resources, Vitae, HRT, NYSE, Workforce, Acquisition, BRL, Growth, Employment, HireRight, Paulo, Airline

With this move, HireRight aims to enhance its support for customers hiring in Brazil, as well as throughout Latin America.

Key Points: 
  • With this move, HireRight aims to enhance its support for customers hiring in Brazil, as well as throughout Latin America.
  • "We are thrilled to grow our Latin America footprint into Brazil to better serve our customers operating in this important market," said Guy Abramo, President and CEO of HireRight.
  • With its new operating entity in Brazil, HireRight aims to provide faster data to customers screening in Brazil through direct connections to local sources.
  • With this expansion, HireRight is well-positioned to further strengthen its market position in Latin America, deliver exceptional local support, and foster mutually beneficial partnerships across the region.

Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

Retrieved on: 
Tuesday, October 17, 2023
Health, Technology, Health Technology, Nanotechnology, Artificial Intelligence, Biotechnology, Vitae, Cyrus, IPD, Scripps Research, Drug development, Machine learning, Bristol Myers Squibb, Berkeley, Coronavirus Scientific Advisory Board, University, Artificial intelligence, Therapy, Affymetrix, Protein, Molecular biology, Cell biology, Drug discovery, ARCH Venture Partners, Harmon, Pharmaceutical industry, Vilya, Muller's morphs

VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.

Key Points: 
  • VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.
  • “I am very excited to join the phenomenal team at Vilya developing new macrocycle drugs,” said Harmon.
  • Previously, Harmon co-founded and served as CEO of Olema Oncology, a company focused on women’s cancers, before transitioning to the role of Chief Research Officer.
  • Harmon joins Katerina Leftheris, Ph.D., Vilya’s Chief Scientific Officer on the company’s leadership team.

VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally

Retrieved on: 
Monday, August 7, 2023
Vitae, Investigational device exemption, Hangzhou, Marketing, Adrenal insufficiency, COVID-19, Clinical trial, Multimedia, Medical Device Regulation Act, RVOT, MDR, PMA, Hospital, Patient, Collection, PMDA, TAVR, United Kingdom, Entrepreneurship, Mortality, IDE, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Medical device, Medical imaging

VenusP-Valve, thus, has become the first China-developed heart valvular system to be approved by the FDA for clinical trial, setting a new milestone in the global footprint of Chinese valves.

Key Points: 
  • VenusP-Valve, thus, has become the first China-developed heart valvular system to be approved by the FDA for clinical trial, setting a new milestone in the global footprint of Chinese valves.
  • IDE refers to the exemption of medical devices intended for marketing from regulatory requirements, allowing clinical trials to be conducted on such devices.
  • The announced IDE approval will allow VenusP-Valve to initiate pivotal clinical trials in the U.S. to support the Pre-Market Approval (PMA).
  • As the first self-expanding TPVR product approved in China and Europe, VenusP-Valve carries remarkable clinical value.

ikaun Announces CV Automation Powering World Class Experience Management Platform

Retrieved on: 
Wednesday, August 2, 2023
Vitae, CVS, RFP, Organization, US Standard Light Rail Vehicle, Europass, AI, System, CV, Collection, Curriculum, World Bank, Automation, Product strategy, Video game, Sales

IRVINE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- ikaun, the AI-powered, world class experience management platform for law firms and professional services organizations, today announces the release of CV Automation, a powerful new feature in the ikaun platform that radically simplifies the search for accurate CVs and resumes and enables very large packages of perfectly consistent, branded CVs to be instantly downloaded at the touch of a button and exported to a wide variety of standard bid formats such as World Bank, US Standard Form 220 and European Curriculum Vitae.

Key Points: 
  • ikaun, the AI-powered, world class experience management platform for law firms and professional services organizations, today announces the release of CV Automation, a powerful new feature in the ikaun platform that radically simplifies the search for accurate CVs and resumes and enables very large packages of perfectly consistent, branded CVs to be instantly downloaded at the touch of a button and exported to a wide variety of standard bid formats such as World Bank, US Standard Form 220 and European Curriculum Vitae.
  • IRVINE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- ikaun , the AI-powered, world class experience management platform for law firms and professional services organizations, today announces the release of CV Automation, a powerful new feature in the ikaun platform that radically simplifies the search for accurate CVs and resumes and enables very large packages of perfectly consistent, branded CVs to be instantly downloaded at the touch of a button and exported to a wide variety of standard bid formats such as World Bank, US Standard Form 220 and European Curriculum Vitae.
  • By centralizing access to all CVs within the organization in an elegant, searchable platform, and directly delivering automated CV updates through project database and profile integrations, CV Automation helps bid, proposal and staffing professionals eliminate onerous, stressful, error-prone searches and win back time with a seamless, frictionless process.
  • Jason Noble, ikaun's Chief of Product Strategy, comments: "With CV Automation, we've attacked a monumental pain point experienced by so many professional services organizations in the collection and production of experience information from, often, thousands of professionals.

FSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directors

Retrieved on: 
Thursday, May 25, 2023
Biotechnology, General Health, Pharmaceutical, Health, Vitae, Federal Advisory Council, United Nations Association of the Philippines, CSE, United Nations, Central Toronto Youth Services, FSD, Meritorious Service Cross, Long-term care, Public, Children and Youth Services Review, Hope, Public policy, Canadian House of Commons Standing Committee on Citizenship and Immigration, FRA, Government, Science, Implementation, Ministry, Partner, Economic development, Knowledge, Governor, Curriculum, War Child (charity), United Nations Association, Pharmaceutical industry, Medical device, Citizenship, Employment

Effective at the same time was the resignation of Donal Carroll from the Board of Directors.

Key Points: 
  • Effective at the same time was the resignation of Donal Carroll from the Board of Directors.
  • Dr. Hoskins is a medical doctor specialized in public health and presently a Partner at Maverix Private Equity in Toronto.
  • From 2014 to 2018, he was Ontario’s Minister of Health and Long-Term Care.
  • As a tireless health advocate, Dr. Hoskins also has many years’ experience creating and delivering health programs in Africa and the Middle East.

Beyond the Dispensary: Gotham Brings its Cannabis and Cultural Concept Store to Downtown NYC

Retrieved on: 
Wednesday, May 10, 2023
Vitae, Bowery, NFT, Education, Face, Parachute, Happening, Black, Bright Moments, Wilson, Social justice, Social change, CBD, Cannabis, Growth, Environment, House, Empowerment, Fashion design, Drug, Noma

NEW YORK, May 10, 2023 /PRNewswire/ -- Gotham, a new, artfully curated cannabis concept store, announced today the opening of its flagship on May 11, 2023 at 10:00 a.m. Located in the Bowery in New York City, the two-story retail and gallery space designed by Cinema Vitae will feature Gotham-branded products, premium cannabis, fashion and lifestyle brands, as well as art exhibitions in a beautifully designed environment.

Key Points: 
  • Gotham, NYC's 1st luxury cannabis and cultural concept store opens on May 11, 2023.
  • Gotham works with best-in-class brands offering New York State's finest cannabis products, including flower, edibles, vaporizers, pre-rolls, and tinctures.
  • In addition to evolving the cannabis retail environment, Gotham brings back the quintessential in-person shopping experience to create community and connection, much like cannabis does.
  • Gotham is a true concept store where visitors can discover something new, browse high end brands and enjoy incredible art through a distinctive NYC lens.